The Peptide Wiki
Mapping Knowledge.
Advancing Discovery.
Last updated
Peptide Profile

Letrozole: Research, Dosing, and Where to Buy in 2026

A research-first profile for Letrozole (letro), aggregating mechanism notes, transcript dosing mentions, vendor recommendations, and PubMed-indexed literature without presenting medical guidance.

โš•๏ธ US PRESCRIPTION REQUIRED. Letrozole is a prescription medication in the United States. Prescription and controlled-substance rules differ by country, so check your local laws before any purchase or use. Information on this page is educational and not medical advice. Consult a licensed prescribing physician.
Quick Answer

Letrozole is a research compound profiled here from named-expert transcripts and peer-reviewed literature, without medical guidance. As of July 2026, The Peptide Wiki aggregates 8 PubMed-cited papers, 3 attributed expert mentions, and 2 transcript dosing protocols for Letrozole, each linked to its source.

Key Facts
Pharmaceutical
  • Also indexed as letro.
  • 2 aggregated dosing-protocol mentions from source transcripts.
  • 8 PubMed-indexed citations listed in the research table below.
  • 0 vendor recommendations captured from named experts.
Sourced to expert
Check vendor COA
Verify dose w/ clinician

What is Letrozole?

Research compound aggregated from creator and literature mentions. No direct disease-treatment claims are made on this page.

Experts on background and overview ยท 3 cited mentions

"Once you have solid gyno tissue, no matter how many letrozole, raloxifene, whatever genie magic protocol you read on the internet, the only way that's getting out is through surgery."
Dean ยท The ULTIMATE Hair Loss & Gyno Prevention Tier List (No... @ 12:27
"How many guys do you know that 'Oh, I have a little bit of high estrogen. 2.5 mg of letrozole per day, baby.' And then they can't poop. Especially during peak week."
Vigorous Steve ยท The ULTIMATE Hair Loss & Gyno Prevention Tier List (No... @ 1:35:32
"you want to crush the estradiol with an aromatase inhibitor like Arimidex or letrozole or exemestane"
Vigorous Steve ยท Underdosed Test Epidemic, Tren Sleep Aids, High-Dose GH... @ 43:42

Letrozole Dosing Protocols

The entries below are transcript-derived dosing mentions. They are preserved for research context and are not medical advice.

SpeakerSourceTimestampProtocolEvidence
Vigorous Steve The ULTIMATE Hair Loss & Gyno Prevention Tier List (No Surgery Required) 01:35:31 2.5 mg letrozole per day mentioned as excessive dose causing constipation anecdotal
Leo and Longevity (Lucie) How to Improve Cognitive Brain Function from a Neuroscientist 00:22:58 2.5 mg once a week anecdotal

Where to Buy Letrozole in 2026

No tracked vendor recommendations for Letrozole yet. See our vendor directory.

Side Effects and Safety

Anecdotal reports and study-level observations vary by route, dose, and individual. This page does not provide medical advice. Consult a qualified clinician before any research use.

What Experts Say

2 experts across our source library discuss Letrozole. Each entry is that expert’s most context-rich mention: click to watch it at the exact timestamp in the original video. Quotes are also emitted as Schema.org Quotation JSON-LD for AI assistants.

  1. Dean ยท The ULTIMATE Hair Loss & Gyno Prevention Tier List (No...Watch @ 12:27 ↗

    “Once you have solid gyno tissue, no matter how many letrozole, raloxifene, whatever genie magic protocol you read on the internet, the only way that's getting out is through surgery.”

  2. Vigorous Steve ยท The ULTIMATE Hair Loss & Gyno Prevention Tier List (No...Watch @ 1:35:32 ↗

    “How many guys do you know that 'Oh, I have a little bit of high estrogen. 2.5 mg of letrozole per day, baby.' And then they can't poop. Especially during peak week.”

See 1 more expert mention →
  1. Vigorous Steve ยท Underdosed Test Epidemic, Tren Sleep Aids, High-Dose...Watch @ 43:42 ↗

    “you want to crush the estradiol with an aromatase inhibitor like Arimidex or letrozole or exemestane”

User Reviews

User reviews aggregator coming Q3 2026 (Reddit + YouTube comments + Discord research notes). Until then, see the expert quote section above and PubMed citations below.

Research Efficacy Snapshot

Published efficacy percentages cited in PubMed trials and named-expert reports about Letrozole. Each line links to the original source.

  • "It affects about 5% to 20% of women worldwide and often leads to anovulatory infertility." ยท Franik S et al, 2022 PubMed
  • "We pooled trials where appropriate using a fixed-effect model to calculate odds ratios (ORs) and 95% confidence intervals (CIs) for most outcomes, and risk differences (RDs) for ovarian hyperstimulation syndrome (OHSS)." ยท Franik S et al, 2022 PubMed
  • "There is evidence for a higher pregnancy rate in favour of letrozole (OR 1.69, 95% CI 1.45 to 1.98; I2 = 0%; NNTB = 10; 23 trials, 3321 participants; high-certainty evidence)." ยท Franik S et al, 2022 PubMed
  • "This suggests that in women with a 22% chance of live birth using LOD with or without adjuncts, the live birth rate in women using letrozole with or without adjuncts would be 24% to 47%." ยท Franik S et al, 2022 PubMed
  • "Due to the low-certainty evidence we are uncertain if letrozole improves pregnancy rates compared to LOD (OR 1.47, 95% CI 0.95 to 2.28; I² = 0%; 3 trials, 367 participants; low-certainty evidence)." ยท Franik S et al, 2022 PubMed
  • "This suggests that in women with a 29% chance of clinical pregnancy using LOD with or without adjuncts, the clinical pregnancy rate in women using letrozole with or without adjuncts would be 28% to 45%." ยท Franik S et al, 2022 PubMed
  • "There seems to be no evidence of a difference in miscarriage rates per pregnancy comparing letrozole to LOD (OR 0.65, 95% CI 0.22 to 1.92; I² = 0%; 3 trials, 122 participants; low-certainty evidence)." ยท Franik S et al, 2022 PubMed
  • "This also applies to multiple pregnancies (OR 3.00, 95% CI 0.12 to 74.90; 1 trial, 141 participants; very low-certainty evidence)." ยท Franik S et al, 2022 PubMed
  • "The median progression-free survival was 24.8 months (95% confidence interval [CI], 22.1 to not estimable) in the palbociclib-letrozole group, as compared with 14.5 months (95% CI, 12.9 to 17.1) in the placebo-letrozole group (hazard ratio for disease progression or death, 0.58; 95% CI, 0.46 to 0.72; P<0.001)." ยท Finn R et al, 2016 PubMed
  • "The most common grade 3 or 4 adverse events were neutropenia (occurring in 66.4% of the patients in the palbociclib-letrozole group vs." ยท Finn R et al, 2016 PubMed

Research and Studies

8 PubMed-indexed papers reference Letrozole. Top 8 shown.

Frequently Asked Questions

Is Letrozole FDA-approved?

Letrozole is presented on this page as a research compound. FDA approval status, scheduling, and state-specific rules may apply and change. Verify current regulatory status before any decision.

What dosing is reported for Letrozole?

This page aggregates 2 dosing-protocol mention(s) from named-expert transcripts, each linked to a verbatim source timestamp. See the Dosing Protocols table above. Mentions are anecdotal, not medical advice.

How much research has been published on Letrozole?

8 PubMed-indexed paper(s) reference Letrozole in our current research feed. See the Research and Studies section above for citations.